Compare GSK plc (GSK) vs TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock (TTWO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GSK plc vs TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock — how do they compare? GSK plc trades at $52.72 (market cap $101.34B), while TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock trades at $242.94 (market cap $45.27B). The key difference: GSK plc is far larger — about 2.2× TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock's market cap, and GSK plc pays a 3.49% dividend while TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock pays none. Which is the better fit depends on your goals.
| GSK | TTWO | |
|---|---|---|
Market Cap | $101.34B | $45.27B |
Sector | Health | Media |
52-Week High | $61.18 | $262.29 |
52-Week Low | $36.20 | $189.69 |
Enterprise Value | $121.95B | $46.23B |
Dividend Yield | 3.49% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GSK trades at $52.64, up 2.7% on the day, with a bearish technical signal despite recent earnings beats. The company reported Q1 2026 EPS of $1.24, beating estimates of $1.16, and maintains strong profitability with a 17.78% net income margin. Positive clinical trial results for Jemperli in rectal cancer and FDA approval for Utebzi highlight pipeline strength, while a pending acquisition of Nuvalent, Inc. signals strategic expansion.
GSK offers value with a P/E of 13.71 and stable cash flows, but faces risks from clinical setbacks, as seen in the terminated Alector partnership. Analyst sentiment is mixed with 31% buy ratings, reflecting cautious optimism amid competitive and regulatory pressures. The stock's outlook hinges on execution of growth initiatives and pipeline developments.
Take-Two Interactive (TTWO) trades at $242.40, up 2.27% with bullish technical signals and strong analyst support. The stock shows consistent earnings beats, with Q1 2026 EPS of $0.80 surpassing the $0.563 estimate. Recent news highlights Grand Theft Auto VI pre-orders beginning June 25, 2026, priced at $79.99, driving positive sentiment. Despite a negative net income margin of -4.48% in 2025, revenue grew to $5.63B, and the company maintains a solid cash position of $1.47B.
The outlook is optimistic due to GTA VI's upcoming launch, with analysts projecting a consensus price target of $302.50. Risks include high debt levels and profitability challenges, but institutional bullishness and technical strength suggest potential upside. Investors should monitor execution on game launches and margin improvement for sustained growth.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GSK plc
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →About TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock
Found in 1993, Take-Two consists of three wholly owned labels, Rockstar Games, 2K, and Zynga. The firm is one of the world's largest independent video game publishers on consoles, PCs, smartphones, and tablets. Take-Two's franchise portfolio is headlined by Grand Theft Auto (345 million units sold) and contains other well-known titles such as NBA 2K, Civilization, Borderlands, Bioshock, and Xcom. Zynga mobile titles include Farmville, Empires & Puzzles, and CSR Racing.
Read more on TTWO →
